Low-Dose BCMA CAR-T Therapy Anito-Cel Eradicates Myeloma in All 38 Phase 1 Patients
A phase 1 trial found that the investigational BCMA-targeted CAR-T therapy anito-cel produced responses in all 38 participants with relapsed ...
A phase 1 trial found that the investigational BCMA-targeted CAR-T therapy anito-cel produced responses in all 38 participants with relapsed ...
A prospective real-world cohort study finds that proteasome inhibitor-based therapy is not associated with measurable differences in quality of life, ...
The British Journal of Cancer has retracted a 2014 study linking chromatin structure and DNA repair to chemotherapy outcomes in ...
A Japanese case report describes how the myeloma drug pomalidomide rapidly relieved transfusion-dependent nosebleeds in a patient with hereditary hemorrhagic ...
A study of Zambian multiple myeloma patients shows their neutrophils have severely impaired phagocytosis and oxidative burst despite normal blood ...
New research reveals that resistant myeloma cells import putrescine through the transporter SLC45A4, activating HOXA1-driven NF-kappaB signaling with help from ...
A new review argues that stable isotope fractionation patterns, long used to reconstruct Earth's history, could become mechanistic biomarkers for ...
A large matched cohort study using U.S. electronic health records finds that patients with pityriasis rubra pilaris have significantly higher ...
A paired study of 44 multiple myeloma patient-caregiver dyads in Seoul finds that patients and caregivers face nearly identical life ...
The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent effectiveness, and stable quality ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine